Drug trials are underway on a potential new Alzheimer’s solution at the University of Colorado Anschutz Medical Campus. After 190 drug failures for the disease, will No. 191 be the “silver bullet?”
Senior living in Denver, unfortunately, understands all too well the struggles that come along with Alzheimers. This devastating disease takes memories away from our loved ones and research to combat it, is still ongoing. Researchers at the CU Anschutz Medical Campus are conducting studies and tests on a new drug that has shown promising results in the fight against Alzheimer’s.
One hundred and ninety other drugs for the treatment of Alzheimers have already failed in medical trials. But this one—called Leukine — is beginning to show encouraging results. A team of doctors there are conducting studies on a drug that could be the first in a new “class” of medications that could actually reverse the course of the disease.
“We found so far that Leukine is safe in people with Alzheimer’s disease,” Potter said. “That means that it doesn’t have the side effects that so many other Alzheimer’s drugs have had, which are swelling in the brain and bleeding into the brain.”
Article Source right here: A promising new treatment for Alzheimer’s